Form 4: Cingulate Inc. Executive Acquires Stock Options
SEC Form 4 Filing
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc., reports acquisition of stock options.
Summary
- On September 30, 2024, Matthew Brams, the EVP and Chief Medical Officer of Cingulate Inc., acquired 1,000 stock options with an exercise price of $5.04.
- The options, granting the right to buy 1,000 shares of common stock, were granted pursuant to the terms of Mr. Bram's Employment Agreement, as amended.
- The options are exercisable from September 30, 2024, and expire on September 30, 2034.
- Following the transaction, Mr. Brams directly owns 1,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock option grants to an executive.
Industry Context
This is a standard Form 4 filing, indicating a change in beneficial ownership by a company insider. It's a routine part of corporate governance and transparency.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of the stock option transaction. |
| 09/30/2024 | Date the stock options become exercisable. |
| 09/30/2034 | Expiration date of the stock options. |
| 10/01/2024 | Date of the signature on the Form 4 filing. |
Keywords
stock options, Cingulate Inc., Matthew Brams, EVP, Chief Medical Officer, Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.